PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx

PLoS Pathogens

Volumn 11, Issue 11, 2015, Pages

  Dutrieux, Jacques ^a   Maarifi, Ghizlane ^a   Portilho, Débora M ^b   Arhel, Nathalie J ^b   Chelbi Alix, Mounira K ^a   Nisole, Sébastien ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DAXX PROTEIN; MESSENGER RNA; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN S 100; SUMO PROTEIN; TRIPARTITE MOTIF PROTEIN 19; UNCLASSIFIED DRUG; VIRUS RNA; DAXX PROTEIN, HUMAN; NUCLEAR PROTEIN; PML PROTEIN, HUMAN; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; LIFE CYCLE STAGE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETROVIRIDAE; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL NUCLEUS; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL NUCLEUS; HIV-1; HUMANS; NUCLEAR PROTEINS; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84948977407     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005280     Document Type: Article

References (60)

1. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848–853. 14985764
2. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD, (2004) Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A 101: 10774–10779. 15249685
3. Keckesova Z, Ylinen LM, Towers GJ, (2004) The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A 101: 10780–10785. 15249687
4. Yap MW, Nisole S, Lynch C, Stoye JP, (2004) Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101: 10786–10791. 15249690
5. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. (2001) The tripartite motif family identifies cell compartments. EMBO J 20: 2140–2151. 11331580
6. Rajsbaum R, Garcia-Sastre A, Versteeg GA, (2014) TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J Mol Biol 426: 1265–1284. doi: 10.1016/j.jmb.2013.12.005 24333484
7. Tissot C, Mechti N, (1995) Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 270: 14891–14898. 7797467
8. Barr SD, Smiley JR, Bushman FD, (2008) The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog 4: e1000007. doi: 10.1371/journal.ppat.1000007 18389079
9. Uchil PD, Quinlan BD, Chan WT, Luna JM, Mothes W, (2008) TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog 4: e16. doi: 10.1371/journal.ppat.0040016 18248090
10. Nisole S, Stoye JP, Saib A, (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3: 799–808. 16175175
11. Gao B, Duan Z, Xu W, Xiong S, (2009) Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50: 424–433. doi: 10.1002/hep.23011 19585648
12. Eldin P, Papon L, Oteiza A, Brocchi E, Lawson TG, et al. (2009) TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J Gen Virol 90: 536–545. doi: 10.1099/vir.0.006288-0 19218198
13. Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers GJ, et al. (2013) TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation. J Virol 87: 4523–4533. doi: 10.1128/JVI.02548-12 23408607
14. Regad T, Saib A, Lallemand-Breitenbach V, Pandolfi PP, de The H, et al. (2001) PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. Embo J 20: 3495–3505. 11432836
15. Pampin M, Simonin Y, Blondel B, Percherancier Y, Chelbi-Alix MK, (2006) Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol 80: 8582–8592. 16912307
16. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MHM, de The H, (1998) Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72: 1043–1051. 9444998
17. Blondel D, Kheddache S, Lahaye X, Dianoux L, Chelbi-Alix MK, (2010) Resistance to rabies virus infection conferred by the PMLIV isoform. J Virol 84: 10719–10726. doi: 10.1128/JVI.01286-10 20702643
18. Maroui MA, Pampin M, Chelbi-Alix MK, (2011) Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies. J Virol 85: 13164–13173. doi: 10.1128/JVI.05808-11 21994459
19. Mitchell AM, Hirsch ML, Li C, Samulski RJ, (2014) Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication. J Virol 88: 925–936. doi: 10.1128/JVI.02922-13 24198403
20. El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, et al. (2014) Implication of PMLIV in both intrinsic and innate immunity. PLoS Pathog 10: e1003975. doi: 10.1371/journal.ppat.1003975 24586174
21. Turelli P, Doucas V, Craig E, Mangeat B, Klages N, et al. (2001) Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol Cell 7: 1245–1254. 11430827
22. Berthoux L, Towers GJ, Gurer C, Salomoni P, Pandolfi PP, et al. (2003) As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J Virol 77: 3167–3180. 12584341
23. Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK, (2013) Differential Roles of PML Isoforms. Front Oncol 3: 125. doi: 10.3389/fonc.2013.00125 23734343
24. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, et al. (1999) PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147: 221–234. 10525530
25. Lallemand-Breitenbach V, de The H, (2010) PML nuclear bodies. Cold Spring Harb Perspect Biol 2: a000661. doi: 10.1101/cshperspect.a000661 20452955
26. Bernardi R, Papa A, Pandolfi PP, (2008) Regulation of apoptosis by PML and the PML-NBs. Oncogene 27: 6299–6312. doi: 10.1038/onc.2008.305 18931695
27. Everett RD, Chelbi-Alix MK, (2007) PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89(6–7): 819–830. 17343971
28. Geoffroy MC, Chelbi-Alix MK, (2011) Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res 31: 145–158. doi: 10.1089/jir.2010.0111 21198351
29. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, et al. (1998) PML is essential for multiple apoptotic pathways. Nat Genet 20: 266–272. 9806545
30. Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, et al. (2008) Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol 10: 547–555. doi: 10.1038/ncb1717 18408733
31. Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, et al. (2008) RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 10(5): 538–546. doi: 10.1038/ncb1716 18408734
32. Muller S, Matunis MJ, Dejean A, (1998) Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. Embo J 17: 61–70. 9427741
33. Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, et al. (2009) Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 16: 133–140. doi: 10.1016/j.chembiol.2009.01.009 19246003
34. Dewannieux M, Dupressoir A, Harper F, Pierron G, Heidmann T, (2004) Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells. Nat Genet 36: 534–539. 15107856
35. Ribet D, Dewannieux M, Heidmann T, (2004) An active murine transposon family pair: retrotransposition of "master" MusD copies and ETn trans-mobilization. Genome Res 14: 2261–2267. 15479948
36. Borden KL, Campbell Dwyer EJ, Salvato MS, (1998) An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72: 758–766. 9420283
37. Blondel D, Regad T, Poisson N, Pavie B, Harper F, et al. (2002) Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21: 7957–7970. 12439746
38. Jin G, Gao Y, Lin HK, (2014) Cytoplasmic PML: from molecular regulation to biological functions. J Cell Biochem 115: 812–818. doi: 10.1002/jcb.24727 24288198
39. Carracedo A, Ito K, Pandolfi PP, (2011) The nuclear bodies inside out: PML conquers the cytoplasm. Curr Opin Cell Biol 23: 360–366. doi: 10.1016/j.ceb.2011.03.011 21501958
40. Lin HK, Bergmann S, Pandolfi PP, (2004) Cytoplasmic PML function in TGF-beta signalling. Nature 431: 205–211. 15356634
41. McNally BA, Trgovcich J, Maul GG, Liu Y, Zheng P, (2008) A role for cytoplasmic PML in cellular resistance to viral infection. PLoS One 3: e2277. doi: 10.1371/journal.pone.0002277 18509536
42. Li H, Leo C, Zhu J, Wu X, O'Neil J, et al. (2000) Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol 20: 1784–1796. 10669754
43. Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, et al. (2006) Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell 24: 341–354. 17081986
44. Lindsay CR, Morozov VM, Ishov AM, (2008) PML NBs (ND10) and Daxx: from nuclear structure to protein function. Front Biosci 13: 7132–7142. 18508722
45. Yang X, Khosravi-Far R, Chang HY, Baltimore D, (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067–1076. 9215629
46. Schreiner S, Wodrich H, (2013) Virion factors that target Daxx to overcome intrinsic immunity. J Virol 87: 10412–10422. doi: 10.1128/JVI.00425-13 23864634
47. Shalginskikh N, Poleshko A, Skalka AM, Katz RA, (2013) Retroviral DNA methylation and epigenetic repression are mediated by the antiviral host protein Daxx. J Virol 87: 2137–2150. doi: 10.1128/JVI.02026-12 23221555
48. Greger JG, Katz RA, Ishov AM, Maul GG, Skalka AM, (2005) The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription. J Virol 79: 4610–4618. 15795247
49. Gurer C, Berthoux L, Luban J, (2005) Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol 79: 910–917. 15613319
50. Zamborlini A, Coiffic A, Beauclair G, Delelis O, Paris J, et al. (2011) Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect. J Biol Chem 286: 21013–21022. doi: 10.1074/jbc.M110.189274 21454548
51. Huang L, Xu GL, Zhang JQ, Tian L, Xue JL, et al. (2008) Daxx interacts with HIV-1 integrase and inhibits lentiviral gene expression. Biochem Biophys Res Commun 373: 241–245. doi: 10.1016/j.bbrc.2008.06.017 18558084
52. Warren K, Warrilow D, Meredith L, Harrich D, (2009) Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription. Viruses 1: 873–894. doi: 10.3390/v1030873 21994574
53. Gao D, Wu J, Wu YT, Du F, Aroh C, et al. (2013) Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341: 903–906. doi: 10.1126/science.1240933 23929945
54. Jakobsen MR, Bak RO, Andersen A, Berg RK, Jensen SB, et al. (2013) IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A 110: E4571–4580. doi: 10.1073/pnas.1311669110 24154727
55. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, et al. (2010) A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467: 214–217. doi: 10.1038/nature09337 20829794
56. Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, et al. (2013) HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503: 402–405. doi: 10.1038/nature12769 24196705
57. Lahaye X, Satoh T, Gentili M, Cerboni S, Conrad C, et al. (2013) The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39: 1132–1142. doi: 10.1016/j.immuni.2013.11.002 24269171
58. Ishov AM, Vladimirova OV, Maul GG, (2004) Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J Cell Sci 117: 3807–3820. 15252119
59. Kuroki M, Ariumi Y, Ikeda M, Dansako H, Wakita T, et al. (2009) Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress. J Virol 83: 2338–2348. doi: 10.1128/JVI.01840-08 19109388
60. Corpet A, Olbrich T, Gwerder M, Fink D, Stucki M, (2014) Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle 13: 249–267. doi: 10.4161/cc.26988 24200965